Janssen

December 16, 2019December 16, 2019

FDA Approves Avsola, Remicade Biosimilar, to Treat Crohn’s Disease and Ulcerative Colitis

News

The U.S. Food and Drug Administration (FDA) has approved Amgen’s Avsola (infliximab-axxq) — a biosimilar to Janssen’s Remicade (infliximab) — to treat adults and children with moderate-to-severe Crohn’s disease (CD) ... Read more

April 25, 2019April 23, 2019

Skin Deep: Dermatological Symptoms of IBD

Columns, Intestinal Fortitude - a Column by Emmeline Olson

In terms of physical disabilities, inflammatory bowel disease (IBD) falls into the “invisible” category. Most of the time, you can’t tell someone has IBD just by looking at them because ... Read more

March 13, 2019March 13, 2019

First Patient Dosed in Phase 2b/3 Study of TD-1473 for Ulcerative Colitis

News

Theravance Biopharma announced that the first patient has been dosed in a Phase 2b/3 study to test the efficacy and safety of its candidate oral drug TD-1473 for the treatment ... Read more

November 28, 2018November 28, 2018

Cosentyx May Increase Risk for Inflammatory Bowel Disease, Italian Researchers Say

News

Italian researchers are calling attention to what they say is an alarming number of newly diagnosed cases of inflammatory bowel disease (IBD) in people treated with the human monoclonal antibody ... Read more

August 27, 2018August 24, 2018

My Colon Remains Dysfunctional, Even After Surgery

Columns, Finding the Silver Linings - a column by Lisa Burks

Having surgeries for IBD isn’t uncommon. In July 2015, I had a left hemicolectomy. Diagnosed with Crohn’s for less than a year, I already had a couple of bowel obstructions. Colonoscopies ... Read more

June 13, 2018June 13, 2018

Remicade Eases Anxiety, Improves Quality of Life for Some Crohn’s Patients, China Study Finds

News

Remicade (infliximab) significantly benefitted the mental health of patients newly diagnosed with Crohn’s disease who had responded to the treatment, improving their perceptions of their illness and quality of life, and lowering anxiety levels, a ... Read more

June 11, 2018June 8, 2018

Facing Side Effects from Remicade After Taking Time Off Treatment

Columns, Finding the Silver Linings - a column by Lisa Burks

From last October to April, I was forced to take a break from taking my Remicade (infliximab) infusions. This was due to surgeries and dealing with severe illnesses. I ended ... Read more

March 27, 2018March 27, 2018

An IBD Biologic Does Not Increase Woman’s Risk of Birth Problem, Study Finds

News

Women who take biologics for autoimmune disorders either three months before or during their pregnancy are not at higher risk of a preterm birth or having a smaller than normal ... Read more

February 9, 2018February 8, 2018

The Next Step: Stelara Infusions and Injections

Columns, It Could Be Worse - a column by Mary Horsley

After Remicade (infliximab) and Humira (adalimumab) failed me — along with sulfasalazine, mesalamine, and budesonide — I started the biologic Entyvio (vedolizumab) last June as my main Crohn’s disease management medication. I still didn’t enter ... Read more

October 4, 2017

Proactive Monitoring of Remicade Levels in IBD Patients May Decrease Risk of Hospitalization, Study Finds

News

Proactive monitoring of the levels of Remicade (infliximab) in patients with inflammatory bowel disease (IBD) may help promote patients’ health and decrease their hospital visits, according to scientists from the Center ... Read more